InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by Blackwell Kimberly, Director. Director active across 1 companies, notably Zentalis Pharmaceuticals, Inc.. Cumulatively, 10 filings have been published. The latest transaction was filed on 3 January 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations10 total
€42,0281,000 shares@ €42.02770.015% mcap25.2% of flow
Common Stock
SEC:0001725160-22-000005·
€42,0281,000 shares@ €42.02770.015% mcap12.6% of flow
Common Stock
SEC:0001725160-22-000005:0·
€42,1881,000 shares@ €42.18780.015% mcap25.3% of flow
Common Stock
SEC:0001725160-21-000231·
€42,1881,000 shares@ €42.18780.015% mcap12.7% of flow
Common Stock
SEC:0001725160-21-000231:0·
€41,3611,000 shares@ €41.36130.014% mcap24.8% of flow
Common Stock
SEC:0001725160-21-000210·
€41,3611,000 shares@ €41.36130.014% mcap12.4% of flow
Common Stock
SEC:0001725160-21-000210:0·
€41,1651,000 shares@ €41.16540.014% mcap24.7% of flow
Common Stock
SEC:0001725160-21-000207·
€41,1651,000 shares@ €41.16540.014% mcap12.3% of flow
Common Stock
SEC:0001725160-21-000207:0·
05,000 shares0
Common Stock
SEC:0001725160-21-000143·
05,000 shares0
Common Stock
SEC:0001725160-21-000143:0·
10 of 10 declarations
About Blackwell Kimberly
Kimberly Blackwell is a Board Member at Zentalis Pharmaceuticals, Inc. As a board member, she participates in the governance and strategy of the company. Her experience is an asset for the organization's development.
